Fidelity Medical Clinic vs Pallas Health
Four-week dosing against twelve-week billing at the same $216.
Fidelity Medical Clinic
Editorial
$216/mo
Fidelity Medical Clinic sells compounded semaglutide at $199 for four doses and compounded tirzepatide at $349 for four, each order covering four weeks rather than a calendar month. Converted by month length, the figures ranked here are $216 and $379. The intro orders are $99 and $349 for eight doses, and both require a two-month commitment.
For
- Order contents stated as four doses
- Supplies included with each order
- Intro order priced and dated
Against
- Four weeks is not a calendar month
- Dose-pricing model not published
- Intro order requires two months
Pick it for: Readers who want dose-by-dose pricing they can check
Pallas Health
Editorial
$216/mo
The $199 a month Pallas quotes comes from dividing a $597 twelve-week charge by three, and twelve weeks is 2.76 calendar months, so the figure ranked here is $216; the same correction puts the $897 tirzepatide block at $325. A first month of compounded semaglutide is $139 before either block begins. Provider care and check-ins are described as sitting inside the price, and the rate is stated as holding at every dose.
For
- Seller publishes its own averaging
- Provider care and check-ins included
- Rate stated as flat at every dose
Against
- Card is charged $597 at a time
- First month is cheaper than the rest
- Twelve weeks is the shortest commitment
Pick it for: Readers who want fewer transactions and a longer paid term
Our verdict
The two publish the same figure on entirely different clocks. Fidelity prices four doses across four weeks; Pallas bills every twelve. The same number describes a very different year.
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.